{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:13:30Z","timestamp":1761862410780},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,11,1]],"date-time":"1984-11-01T00:00:00Z","timestamp":468115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1984,11]]},"DOI":"10.1007\/bf00496109","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T12:53:46Z","timestamp":1100696026000},"page":"69-75","source":"Crossref","is-referenced-by-count":68,"title":["Interactions between a ?calcium channel agonist?, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle"],"prefix":"10.1007","volume":"328","author":[{"given":"Michael","family":"Spedding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-4159.1984.tb12729.x","volume":"42","author":"U Albus","year":"1984","unstructured":"Albus U, Habermann E, Ferry DR, Glossmann H (1984) Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent (3H)noradrenaline release from PC12 cells. J Neurochem 42:1186?1189","journal-title":"J Neurochem"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.1984.tb10741.x","volume":"81","author":"T Anno","year":"1984","unstructured":"Anno T, Furuta T, Itoh M, Kodama I, Toyama J, Yamada K (1984) Electromechanical effects of bepridil on rabbit isolated hearts. Br J Pharmacol 81:41?47","journal-title":"Br J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","volume":"14","author":"O Arunlakshana","year":"1959","unstructured":"Arunlakshana O, Schild HO (1959) Some quantitative used of drug antagonists. Br J Pharmacol Chemother 14:48?58","journal-title":"Br J Pharmacol Chemother"},{"key":"CR4","first-page":"53","volume":"5","author":"R Bayer","year":"1982","unstructured":"Bayer R, Kaufmann R, Mannhold R, Rodenkirchen R (1982) The action of specific Ca antagonists on cardiac electrical activity. Progr Pharmacol 5:53?85","journal-title":"Progr Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.80.8.2356","volume":"80","author":"P Bellemann","year":"1983","unstructured":"Bellemann P, Schade A, Towart R (1983) Dihydropyridine receptor in rat brain labelled with (3H)nimodipine. Proc Natl Acad Sci USA 80:2356?2360","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","first-page":"291","volume":"225","author":"GT Bolger","year":"1983","unstructured":"Bolger GT, Gengo P, Klockowski E, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca2+ channel antagonist, (3H)nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291?309","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.1983.tb00538.x","volume":"3","author":"J Bou","year":"1983","unstructured":"Bou J, Llenas J, Massingham R (1983) Calcium entry blocking drugs, ?calcium antagonists? and vascular smooth muscle function. J Auton Pharmacol 3:219?232","journal-title":"J Auton Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0006-291X(82)91838-1","volume":"108","author":"A DePover","year":"1982","unstructured":"DePover A, Matlib MA, Lee SW, Dub\u00e9 GP, Grupp IL, Grupp G, Schwartz A (1982) Specific binding of (3H)nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Comm 108:110?117","journal-title":"Biochem Biophys Res Comm"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0006-291X(82)91339-0","volume":"104","author":"FJ Ehlert","year":"1982","unstructured":"Ehlert FJ, Itoga E, Roeske WR, Yamamura HI (1982) The interaction of (3H)nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Comm 104:937?943","journal-title":"Biochem Biophys Res Comm"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00586355","volume":"321","author":"DR Ferry","year":"1982","unstructured":"Ferry DR, Glossmann H (1982) Evidence for multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Arch Pharmacol 321:80?83","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR11","unstructured":"Fleckenstein A (1981) Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes. In: Weiss GB (ed) New perspectives on calcium antagonists. Am Physiol Soc Baltimore, pp 59?81"},{"key":"CR12","unstructured":"Gittos M, Spedding M (1984) Comparison of cis and trans diclofurime with verapamil as calcium antagonists. Br J Pharmacol 81:81P"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0165-6147(82)91221-4","volume":"3","author":"H Glossmann","year":"1982","unstructured":"Glossmann H, Ferry DR, L\u00fcbbecke F, Mewes R, Hofmann F (1982) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431?437","journal-title":"Trends Pharmacol Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0014-5793(83)80972-7","volume":"160","author":"H Glossmann","year":"1983","unstructured":"Glossmann H, Linn T, Rombusch M, Ferry DR (1983) Temperature-dependent regulation of d-cis-(3H)diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. FEBS Lett 160:226?232","journal-title":"FEBS Lett"},{"key":"CR15","first-page":"167","volume":"268","author":"T Godfraind","year":"1984","unstructured":"Godfraind T, Hardy JP, Morel N (1984) The action of the spasmogenic dihydropyridine Bay K 8644 on the mechanical and the electrical activity of guinea-pig taenia coli. Arch int Pharmacodyn Ther 268:167?168","journal-title":"Arch int Pharmacodyn Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1073\/pnas.80.16.5122","volume":"80","author":"RJ Gould","year":"1983","unstructured":"Gould RJ, Murphy KMM, Reynolds IJ, Snyder SH (1983) Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci USA 80:5122?5125","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0165-6147(84)90382-1","volume":"5","author":"RP Hof","year":"1984","unstructured":"Hof RP (1984) Selective effects of different calcium antagonists on the peripheral circulation. Trends Pharmacol Sci 5:100?103","journal-title":"Trends Pharmacol Sci"},{"key":"CR18","unstructured":"Humphrey PPA, Robertson MJ (1983) Functional characteristics of verapamil and nitrendipine interactions at calcium channels in smooth muscle. Br J Pharmacol 80:502P"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1113\/jphysiol.1976.sp011284","volume":"255","author":"H Inomata","year":"1976","unstructured":"Inomata H, Kao CY (1976) Ionic currents in the guine-pig taenia coli. J Physiol 255:347?378","journal-title":"J Physiol"},{"key":"CR20","first-page":"330","volume":"226","author":"JD Johnson","year":"1983","unstructured":"Johnson JD, Fugman DA (1983) Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments. J Pharmacol Exp Ther 226:330?334","journal-title":"J Pharmacol Exp Ther"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1476-5381.1982.tb09344.x","volume":"77","author":"H Karaki","year":"1982","unstructured":"Karaki H, Murakami K, Nakagawa H, Ozaki H, Urakawa N (1982) Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles. Br J Pharmacol 77:661?666","journal-title":"Br J Pharmacol"},{"key":"CR22","unstructured":"Kazda S, Towart R (1982) The duration of action of calcium antagonists in vitro: a comparison of nifedipine and nisoldipine (Bay K 5552). Br J Pharmacol 76:255P"},{"key":"CR23","first-page":"84","volume":"5","author":"S Kazda","year":"1983","unstructured":"Kazda S, Knorr A, Towart R (1983) Common properties and differences between various calcium antagonists. Progr Pharmacol 5:84?116","journal-title":"Progr Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0006-2952(81)90217-3","volume":"30","author":"Y Landry","year":"1981","unstructured":"Landry Y, Amellal M, Ruckstuhl M (1981) Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol 30:2031?2032","journal-title":"Biochem Pharmacol"},{"key":"CR25","first-page":"454","volume":"208","author":"RM Levin","year":"1979","unstructured":"Levin RM, Weiss GB (1979) Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activation of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther 208:454?459","journal-title":"J Pharmacol Exp Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(84)90128-6","volume":"98","author":"C Lugnier","year":"1984","unstructured":"Lugnier C, Follenius A, Gerard D, Stoclet JC (1984) Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol 98: 157?158","journal-title":"Eur J Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0024-3205(82)90049-2","volume":"31","author":"PJ Marangos","year":"1982","unstructured":"Marangos PJ, Patel J, Miller C, Martino AM (1982) Specific calcium antagonist binding sites in brain. Life Sci 31: 1575?1585","journal-title":"Life Sci"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1073\/pnas.80.3.860","volume":"80","author":"KMM Murphy","year":"1983","unstructured":"Murphy KMM, Gould RJ, Largent BL, Snyder SH (1983) A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci USA 80:860?864","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(80)91303-3","volume":"1","author":"LH Opie","year":"1980","unstructured":"Opie LH (1980) Calcium antagonists. Lancet 1:806?810","journal-title":"Lancet"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(83)90655-6","volume":"95","author":"IJ Reynolds","year":"1983","unstructured":"Reynolds IJ, Gould RJ, Snyder SH (1983) (3H)Verapamil binding sites in brain and skeletal muscle: regulation by calcium. Eur J Pharmacol 95:315?321","journal-title":"Eur J Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00586921","volume":"351","author":"J Riemer","year":"1974","unstructured":"Riemer J, D\u00f6rfler F, Mayer C-J, Ulbrecht G (1974) Calcium antagonistic effects on the spontaneous activity of guinea-pig taenia coli. Pfl\u00fcger's Arch ges Physiol 351:33?37","journal-title":"Pfl\u00fcger's Arch ges Physiol"},{"key":"CR32","first-page":"9","volume":"5","author":"R Rodenkirchen","year":"1982","unstructured":"Rodenkirchen R, Bayer R, Mannhold R (1982) Specific and non-specific Ca antagonists. A structure-activity analysis of cardiodepressive drugs. Progr Pharmacol 5:9?23","journal-title":"Progr Pharmacol"},{"key":"CR33","first-page":"202","volume":"25","author":"JG Sarmiento","year":"1983","unstructured":"Sarmiento JG, Janis RA, Maurer SC, Katz AM, Triggle DJ, Luchowski E (1983) Comparison of high affinity binding sites for Ca2+ channel inhibitors in membranes for various tissues. Is calmodulin at the binding site for Ca2+ channel inhibitors? Pharmacologist 25:202","journal-title":"Pharmacologist"},{"key":"CR34","first-page":"448","volume":"43","author":"JG Sarmiento","year":"1984","unstructured":"Sarmiento JG, Janis RA, Rampe D, Triggle DJ (1984) (3H) Bay K 8644, a calcium channel agonist, binds to high and low affinity sites on membranes from cardiac muscle and brain. Fed Proc 43:448","journal-title":"Fed Proc"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/303535a0","volume":"309","author":"M Schramm","year":"1983","unstructured":"Schramm M, Thomas G, Towart R, Franckowiak G (1983a) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 309:535?537","journal-title":"Nature"},{"key":"CR36","first-page":"1268","volume":"33","author":"M Schramm","year":"1983","unstructured":"Schramm M, Thomas G, Towart R, Franckowiak G (1983b) Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Arzneim-Forsch 33:1268?1272","journal-title":"Arzneim-Forsch"},{"key":"CR37","unstructured":"Schramm M, Towart R (1984) Modulation of calcium channel function with 1,4-dihydropyridine structure. J Physiol 349: 53P"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-5793(81)80704-1","volume":"125","author":"MP Sparrow","year":"1981","unstructured":"Sparrow MP, Mrwa U, Hofmann F, R\u00fcegg JC (1981) Calmodulin is essential for smooth muscle contractions. FEBS Lett 125: 141?145","journal-title":"FEBS Lett"},{"key":"CR39","unstructured":"Spedding M (1981) Marked differences in the effects of ?Ca2+ antagonists? on CaCl2-induced contractions in K+-depolarized smooth muscle. Br J Pharmacol 72:144P"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00500485","volume":"318","author":"M Spedding","year":"1982","unstructured":"Spedding M (1982a) Assessment of ?Ca2+-antagonist? effects of drugs in K+-depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn-Schmiedeberg's Arch Pharmacol 318: 234?240","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00005344-198211000-00015","volume":"4","author":"M Spedding","year":"1982","unstructured":"Spedding M (1982b) Differences between the effects of calcium antagonists in the pithed rat preparation. J Cardiovasc Pharmacol 4:973?979","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.1983.tb10516.x","volume":"79","author":"M Spedding","year":"1983","unstructured":"Spedding M (1983a) Direct inhibitory effects of some ?calcium antagonists? and trifluoperazine on the contractile proteins in smooth muscle. Br J Pharmacol 79:225?231","journal-title":"Br J Pharmacol"},{"key":"CR43","unstructured":"Spedding M (1983b) The effects of changing surface charge with salicylate on the potency of calcium antagonists in smooth muscle. Br J Pharmacol 78:36P"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1476-5381.1983.tb10719.x","volume":"80","author":"M Spedding","year":"1983","unstructured":"Spedding M (1983c) Functional interactions of calcium antagonists in K+-depolarized smooth muscle. Br J Pharmacol 80: 485?488","journal-title":"Br J Pharmacol"},{"key":"CR45","doi-asserted-by":"crossref","unstructured":"Spedding M (1984a) Changing surface charge with salicylate differentiates between subgroups of calcium antagonists. Br J Pharmacol, in press","DOI":"10.1111\/j.1476-5381.1984.tb10137.x"},{"key":"CR46","doi-asserted-by":"crossref","unstructured":"Spedding M (1984b) Calcium antagonist subgroups. Trends Pharmacol Sci: in press","DOI":"10.1016\/0165-6147(85)90052-5"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1476-5381.1956.tb00006.x","volume":"11","author":"RP Stephenson","year":"1956","unstructured":"Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol Chemother 11:379?393","journal-title":"Br J Pharmacol Chemother"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-6147(84)90386-9","volume":"5","author":"R Towart","year":"1984","unstructured":"Towart R, Schramm M (1984) Recent advances in the pharmacology of the calcium channel. Trends Pharmacol Sci 5:111?113","journal-title":"Trends Pharmacol Sci"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0165-6147(84)90346-8","volume":"5","author":"DJ Triggle","year":"1984","unstructured":"Triggle DJ (1984) Ca2+ channels revisited: problems and promises. Trends Pharmacol Sci 5:4?5","journal-title":"Trends Pharmacol Sci"},{"key":"CR50","first-page":"299","volume":"143","author":"JM Rossum Van","year":"1963","unstructured":"Van Rossum JM (1963) Cumulative dose-response curves II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299?330","journal-title":"Arch Int Pharmacodyn"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(82)90467-8","volume":"85","author":"RM Wadsworth","year":"1983","unstructured":"Wadsworth RM, Moss JP (1983) Time course of the effect of flunarizine on rabbit isolated vascular muscle. Eur J Pharmacol 85:207?209","journal-title":"Eur J Pharmacol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI110596","volume":"70","author":"LT Williams","year":"1982","unstructured":"Williams LT, Tremble P (1982) Binding of a calcium antagonist, (3H)nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J Clin Inv 70:209?212","journal-title":"J Clin Inv"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0006-291X(82)90877-4","volume":"108","author":"HI Yamamura","year":"1982","unstructured":"Yamamura HI, Schoemaker H, Boles RG, Roeske WR (1982) Diltiazem enhancement of (3H)nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Comm 108:640?646","journal-title":"Biochem Biophys Res Comm"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00496109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00496109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00496109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T04:18:06Z","timestamp":1585973886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00496109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,11]]}},"alternative-id":["BF00496109"],"URL":"https:\/\/doi.org\/10.1007\/bf00496109","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,11]]}}}